Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors

Clinical trial NCT03991741 · TERMINATED

Trial details

NCT number: NCT03991741
Sponsor: Gregory Daniels
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma Locally Advanced Refractory/Recurrent Melanoma Metastatic Head and Neck Cancer Locally Advanced Refractory/Recurrent Head and Neck Cancer

Start date: 2020-10-07
Primary completion: 2023-01-26
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.